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Abstract
RNA editing is a process that modifies RNA nucleotides and changes the efficiency and fidelity of the central dogma.
Enzymes that catalyze RNA editing are required for life, and defects in RNA editing are associated with many diseases.
Recent advances in sequencing have enabled the genome-wide identification of RNA editing sites in mammalian
transcriptomes. Here, we demonstrate that canonical RNA editing (A-to-I and C-to-U) occurs in liver, white adipose, and
bone tissues of the laboratory mouse, and we show that apparent non-canonical editing (all other possible base
substitutions) is an artifact of current high-throughput sequencing technology. Further, we report that high-confidence
canonical RNA editing sites can cause non-synonymous amino acid changes and are significantly enriched in 39 UTRs,
specifically at microRNA target sites, suggesting both regulatory and functional consequences for RNA editing.
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Introduction
The commonly taught, simplest version of the central dogma of
molecular biology (DNA to RNA to protein) has been complicated
in recent years by the discoveries of alternative splicing, non-
coding RNAs, and other transcriptional regulatory mechanisms.
RNA editing disrupts the faithful transfer of information from
DNA to RNA to protein by altering the sequence of RNA
molecules co- or post- transcriptionally, potentially altering
translational regulation and leading to a diversified proteome.
RNA editing was first discovered in 1986 in trypanosomes, where
nucleotide insertions cause reading frame shifts [1]. Other forms of
RNA editing, including various nucleotide substitutions, deletions,
and insertions have been observed in organisms ranging from
bacteria to plants to insects to humans [1–4]. In mammals, only
two classes of RNA editing have been well characterized: cytidine
to uridine (C-to-U), and adenosine to inosine (A-to-I). Members of
the cytidine deaminase (AID/APOBEC) family of proteins have
been shown to catalyze C-to-U reactions on both RNA and DNA
substrates [5,6], however, C-to-U RNA editing is thought to be
relatively less common [7]. The majority of known mammalian
RNA editing changes are A-to-I, which can be catalyzed by the
adenosine deaminase (ADAR) family of proteins [8]. Inosine is
read as guanine by reverse transcription and translation
machinery, so this type of editing is sometimes referred to as A-
to-G editing. Deletion of ADAR proteins is lethal for mice, and
dysregulation of A-to-I editing is associated with many diseases,
including neurodegenerative disorders, genodermotosis, and
cancer [4,8,9].
New applications of high-throughput sequencing technology to
RNA have expanded the number of characterized A-to-I and C-
to-U ‘‘canonical’’ editing sites, and several studies have suggested
widespread DNA-RNA differences, including all 10 other possible
‘‘non-canonical’’ base substitutions. However, no enzymes or
biochemical processes have been identified that can catalyze these
non-canonical RNA edits. Initial computational efforts focused on
A-to-I editing and searched through expressed sequence tag (EST)
libraries to identify thousands of candidate sites subsequently
verified through targeted RNA-seq [10]. Several recent studies
utilizing whole-transcriptome RNA-seq have observed both
canonical and non-canonical editing sites in human data,
including over 10,000 exonic editing events in human B-cells
[11], nearly 10,000 sites in a U87MG human glioma cell line [12],
and almost 2,000 sites based on paired RNA-seq and DNA-seq of
human blood samples [13]. All these studies confirmed a subset of
editing sites through Sanger sequencing, and demonstrated that
RNA editing can potentially alter coding sequences [11–13]. The
Li et al. study further demonstrated that at least some editing sites
are translated into peptides detectable by mass spectrometry [11].
Here, we report that canonical RNA editing occurs in multiple
tissues of the important mammalian model organism, the
laboratory mouse; however, we report that apparent non-
canonical editing is likely an artifact of current high-throughput
sequencing technology and analysis limitations.
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We examined RNA editing in the laboratory mouse by
sequencing RNA samples extracted from liver, white adipose,
and bone tissue from three independent C57BL/6J mice. Data
was analyzed by aligning sequenced reads to the mouse reference
genome (NCBI build 37; mm9 from http://genome.ucsc.edu) in a
manner that tolerates a large number of mismatches and the
possibility of reads spanning splice junctions. Potential RNA
editing sites were identified as bases supported by at least 2 high
quality edited reads with an edit ratio (fraction of edited reads vs.
total reads) greater than 5% in all three biological replicates
(details in Methods; summary in Table S1). We observed 366
canonical editing sites (A-to-I or C-to-U; Fig. 1A), including 5 A-
to-I editing sites orthologous to sites previously validated in human
samples (Table S2). Additionally, we observed 683 non-canonical
editing sites (all other base substitutions; Fig. 1A), which is
consistent with recent reports that all twelve base substitutions are
reliably present in RNA-seq [11–13]. However, we observed
striking differences between the canonical and non-canonical
editing sites supported by high-throughput sequencing. The
genomic location of canonical editing sites is significantly biased
towards 39 UTRs (p-value,0.001), suggesting a potential function
(discussed more below), while non-canonical editing sites are
distributed similarly to the genomic background (Fig. 1H). Most
significantly, the majority of our non-canonical editing sites
(,70%) are only supported by reads sequenced in a single
direction (example in Fig. 1C, summary in Fig. 2B), while the
majority of our canonical editing sites are supported by reads
sequenced in both directions (Figs. 1B, 2B). This observation is
consistent with several recent reports of strand-biased systematic
errors present in high-throughput sequencing [14,15]. The
combination of a random genomic distribution and the disparity
in strand bias suggests that non-canonical editing may be a result
of sequencing errors.
In order to verify that apparent non-canonical editing is an
artifact of high-throughput sequencing, we randomly selected 19
canonical and 13 non-canonical editing sites for validation with
Sanger sequencing. RNA (reverse transcribed into cDNA) and
genomic DNA (gDNA) were extracted from two liver or adipose
samples of additional C57BL/6J mice. For each site, the
surrounding region was amplified by PCR from both gDNA and
cDNA, and each was sequenced. All 19 canonical RNA editing
sites were validated in both independent samples through Sanger
sequencing (example in Fig. 1D; full results in Fig S1); while none
of the 13 non-canonical editing sites were validated (example in
Fig. 1E; full results in Fig S2). Further, we validated 1 canonical
editing site (C-to-U; chr10:57235791) by a restriction fragment
length polymorphism (RFLP) assay utilizing an enzyme (BspDI)
that cuts only the edited version of the sequence. These results
agree with the sequencing results in that the cDNA contains both
edited and un-edited forms (since cleaved and un-cleaved products
are visible), while the gDNA contains only the un-edited (un-
cleaved) sequence (Fig. 1F). Similar RFLP analysis of a non-
canonical editing site (G-to-C; chr9:123370996) showed no
cleaved products in cDNA or gDNA (Fig. 1G), confirming Sanger
sequencing results that the site is not truly edited. Although limited
in number, our result of 0 out of 13 non-canonical validations
suggests that no more than 3 of our 683 observed non-canonical
sites are likely to be genuine, assuming a false discovery rate of 5%.
Thus, our results strongly suggest that most canonical editing
targets are truly edited, while most non-canonical editing sites
identified from high-throughput sequencing are not true editing
sites.
Given the large number of observed non-canonical editing sites
that show a strand bias in our RNA-seq data and given that
systematic high-throughput sequencing biases appear to be quite
common [15], it is likely that bias accounts for much of the
Figure 1. Distribution and validation of editing sites observed
in RNA-seq data. A) Distribution of RNA editing types with and
without a filter for significant strand bias from RNA-seq data. B,C) RNA-
seq traces are shown for one canonical RNA editing site (C-to-U in
Serinc1) and for one non-canonical editing site (G-to-C in Lars2). Reads
sequenced in the sense direction are shown in dark grey, while reads
sequenced in the reverse direction are shown in light grey. D,E) Sanger
sequencing validation results for sites in Serinc1 and Lars2. F,G) RFLP
validation of sites in Serinc1 and Lars2. Samples exposed to enzyme are
labeled ‘‘en+’’ and control samples are labeled ‘‘en-.’’ H) Genomic
distribution of editing sites and random background.
doi:10.1371/journal.pone.0033720.g001
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are unable to distinguish genuine editing events from these data.
For example, the editing ratio is higher for non-canonical editing
sites than canonical sites (Figs. 2A, S3). Therefore, we developed a
statistical approach to distinguish true editing sites from those
caused by sequencing errors by calculating whether edited reads
were significantly biased towards one strand using Fisher’s exact
test. By rejecting editing sites with a Bonferroni corrected p-
value,0.05, we eliminate roughly 70% of non-canonical editing
sites (including all 13 non-canonical sites that failed to be
Figure 2. Identification of high-confidence RNA editing sites. A) Distribution of editing ratio for all observed canonical and non-canonical
RNA editing sites in our adipose RNA-seq data shows that the ratio is higher for non-canonical than canonical sites. B) Distribution of Fisher’s exact
test p-values for strand bias. Non-canonical RNA editing sites shows an extreme peak around zero, indicating that most non-canonical RNA editing
sites are supported by strand biased reads. C) Overview of our RNA editing analysis pipeline.
doi:10.1371/journal.pone.0033720.g002
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this filtering, the distribution of all types of RNA editing is heavily
biased towards canonical A-to-I and C-to-U edits, while the bulk
of remaining non-canonical editing sites are complementary to
canonical edits, either T-to-C or G-to-A (Fig. 1A). Importantly,
two of the best characterized Illumina sequencing errors, A-to-C
and T-to-G [15,16] are almost completely eliminated, suggesting
that a strand bias filter may account for most of the RNA-seq
specific artifacts. Also consistent with recent reports, using MEME
[17], we found a significantly enriched GGC[A/T]GG motif near
55% of strand biased sites (305 of 557, p value=8.2e-222) (similar
to [14]) as well as some enrichment for poly-A sequences (7% of
sites, p value=1.7e-100); and we found a tendency for strand
biased sites to be immediately preceded by GG (similar to [15]; all
motifs in Fig S6). We did not observe any consistent motifs near
sites without a strand bias.
To validate the strand bias filter, we selected 3 canonical editing
sites with a significant strand bias for testing (none of the
previously validated 19 canonical editing sites displayed a strand
bias). None of these sites were validated through Sanger
sequencing (Fig S4A), confirming our assessment that strand
biased canonical editing sites are likely artifacts. The remaining
non-canonical editing sites that do not exhibit a strand bias also
appear to be the product of biases or errors, falling into several
categories. First, errors or omissions in the reference genome
relative to our samples can lead to apparent non-canonical editing.
For example, roughly 50% of our observed non-canonical editing
sites without any strand bias are localized to a single gene, Hjurp
(Holiday junction recognition protein; MGI:2685821). Sanger
sequencing of several locations within Hjurp showed mixed
sequencing peaks in both gDNA and cDNA samples (Fig S5),
suggesting that there may be additional polymorphic copies of
Hjurp in our genetic background that are not reflected by the
reference genome, leading to observed editing in our RNA-seq
data. As such, we removed all sites within Hjurp from our final
results. A similar phenomenon could occur because of somatic
mutations, or genetic drift relative to the reference genome.
Apparent non-canonical editing could also be the result of
complementary canonical editing of double stranded substrates or
of antisensetranscripts.Forexample,theAID/APOBEC familyhas
beenshownto edit C-to-UinDNAsequences,which when repaired
can produce a C-to-T edit in the primary strand, and a G-to-A edit
in the complementary strand [7]. A similar phenomenon could
occur in double stranded RNA substrates. Analogously, the ADAR
family of proteins could create A-to-I edits in double stranded
substrates that could be repaired to produce A-to-G edits in the
primary strand, and corresponding T-to-C edits in the comple-
mentary strand. A similar observation could be made if editing
occurs in antisense transcripts because of the non-strand specific
nature of current RNA-seq techniques. During sequencing library
construction, RNA is immediately converted to double stranded
cDNA, removing all information regarding strand of origin. As
such, we (and others [11,13]) make the assumption that transcripts
originated from the sense strand to identify editing sites. However,
recent evidence suggests that antisense transcripts may be broadly
produced [18], in which case, canonical editing of antisense
transcripts would manifest as complementary non-canonical editing
in current RNA-seq data. Interestingly, a recent study examining
RNA editing in the presence of siRNA knockdown of the ADAR
gene family observed a significant decrease in both A-to-G and T-
to-C editing events compared to controls [12]. Complementary
editing potentially explains many non-canonical editing sites
observed in our data, and may explain other observations of non-
canonical editing in the literature.
Due to these potential sequencing errors and biases, we focused
further analyses on a set of replicated, canonical RNA editing sites.
A summary of our overall approach is shown in Fig. 2C. After
applying this RNA-seq data analysis pipeline, including filters for
significant strand biases and non-canonical editing, we identified
207 A-to-I editing sites and 35 C-to-U editing sites with high-
confidence across all three replicates in at least one tissue (Table
S3). These editing sites are significantly biased towards 39 UTRs
(Fig. 1H; hypergeometric p-value,0.001) and against coding
regions (Fig. 1H; p-value,0.001). However, the 12 rare canonical
coding editing sites are 3 fold enriched for non-synonymous amino
acid substitutions, including the 5 sites orthologous to previously
validated human editing sites (Table S2), suggesting that RNA
editing can diversify the transcriptome and proteome.
The majority of our high-confidence RNA editing sites (217 of
242, 90%) occur in 39 UTRs, and of these, they are significantly
biased towards target sites of the predicted ‘‘seeds’’ of microRNAs
(2
nd to 8
th nucleotides of microRNAs, the key positions for
microRNAs to recognize their targets [19]) (94 of 217, 43%; p-
value,0.001). In contrast, non-canonical sites are not enriched at
39UTRs and are weakly enriched at microRNA target sites, but
given that we have been unable to validate any non-canonical
sites, it is unlikely that these edits are genuine. In addition to
disrupting known targets, we also found that a significant number
of our high-confidence sites potentially create new microRNA
target positions (38 of 217, p-value,0.001). Similar results are
obtained when using more sophisticated predictions of microRNA
targets, such as those from the MicroCosm v5 database [20] (p-
value,0.001). This suggests that a primary function of RNA
editing could be in the disruption or creation of microRNA targets
to affect translational regulation or message stability. For example,
in Rpa1 (replication protein A1; MGI:1915525), a gene essential
for replication, recombination, and DNA repair, we observed 12
high-confidence A-to-I editing sites, 7 of which localize to targets
of microRNA seeds. Six of these 7 sites are within 100 nucleotides,
forming a very dense cluster, including a pair of adjacent editing
sites within overlapping targets of microRNAs (Fig. 3). This dense
editing cluster could greatly decrease the interaction efficiency
between Rpa1 and microRNAs. This finding is in contrast to
previous reports based on computational evaluations of human
RNA editing sites, which observed a bias against microRNA target
sites, although they did observe rare examples of RNA editing at
microRNA target sites [21]. In C. elegans, others have shown a
genetic interaction between members of the ADAR protein family
and members of the RNAi pathway [22], suggesting a role for
editing in RNA-mediated interference. Recent efforts have
primarily focused on the direct editing of microRNAs and their
precursors, rather than on their targets [9,23]. Our results suggest
that RNA editing plays a role throughout the entire process of
microRNA-mediated regulation.
Discussion
We have utilized high-throughput sequencing of RNA followed
by rigorous computational analysis to identify a set of 242 very
high-confidence canonical RNA editing sites from multiple tissues
of the laboratory mouse. Given our experimental and computa-
tional results, it is unlikely that non-canonical editing is a true
biological phenomenon. For our specific mouse samples, strand
bias artifacts account for roughly 70% of observed non-canonical
editing sites, reference genome errors account for 15% of artifacts,
and the remaining 15% are likely the product of other reference
genome imperfections, double stranded substrates, antisense
transcripts, or other sources of sequencing error. In addition to
Canonical RNA Editing Enriched at microRNA Targets
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further examined 1 non-canonical site without a significant strand
bias, and it also failed to validate (Fig S4B), suggesting that it may
be a result of sequencing errors other than the strand bias issue,
and that further analysis of high-throughput sequencing errors is
warranted.
Strand bias explains the majority of non-canonical editing sites in
ourdata, whilea smallerminorityarelikely errors orbiasesfrom the
reference genome; but the balance between these factors may be
different for other analysis settings, sequencing platforms, or
organisms. The challenge of incomplete or imperfect reference
genomes is somewhat mitigated by our use of homozygous C57BL/
6J mice, which closely match the NCBI mouse reference genome.
However in other populations or organisms, including human
datasets, genetic diversity, heterozygosity, and varying qualities of
reference genomes will likely present an even greater challenge. In
fact, a recent re-analysis of human B-cell transcriptome data [11]
demonstrates that the majority of editing sites originally identified
may be a product of reference genome discrepancies and resulting
alignment errors [24]. However, our results suggest that even in the
ideal case of a perfect reference genome and alignments, spurious
RNA editing may be observed due to high-throughput sequencing
biases. Future studies of RNA editing must account for both
complications inalignmentsto currentreference genomes, as well as
the biases of sequencing technologies.
Despite mounting evidence from this and other studies, it is
difficult to completely rule out the possibility of rare non-canonical
RNA editing events, especially for editing sites that are
complementary to canonical editing types. Nevertheless, our
results suggest that canonical RNA editing plays both regulatory
and functional roles, as editing sites are significantly biased
towards 39UTRs and microRNA target sites, and can cause non-
synonymous amino acid changes. Although we have some
biochemical knowledge of how the AID/APOBEC and ADAR
gene families catalyze canonical editing, many open questions
remain regarding the regulation and function of RNA editing,
including how sites are targeted for editing and which enzymes
catalyze which targets. As costs decrease and technologies improve
(e.g. single molecule sequencing, strand-specific sequencing,
deeper sequencing coverage), future studies of RNA editing will
be able to address these outstanding issues.
Materials and Methods
Ethics statement
The Institutional ACUC of The Jackson Laboratory approved
the use of mice for this study (approval #11003). All animals were
treated humanely and in strict accordance with the recommen-
dations provided by the National Institutes of Health.
Animals
Samples for RNA-seq were obtained from 16 week old female
C57BL/6J mice (JR stock #000664), which were purchased from
the resource colonies of The Jackson Laboratory (Bar Harbor,
ME). Validation experiments were performed in additional,
independent C57BL/6J mice, one male and one female. Mice
were maintained in polycarbonate boxes (130 cm
2) on bedding of
sterilized white pine shavings under conditions of 12 hours light;
12 hours darkness. All mice had free access to water and rodent
chow for the duration of the study.
Figure 3. Example of RNA editing at microRNA target sites. One hundred nucleotides of the 39UTR of Rpa1 is shown. Multiple microRNA
target sites form a dense cluster in this region and contain many A-to-I editing sites. Red bases represent RNA editing sites, and blue and green bases
represent different microRNA seed locations.
doi:10.1371/journal.pone.0033720.g003
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RNA was isolated from white adipose, liver, and femurs of three
independent animals. RNA-seq was performed using an Illumina
GAIIx instrument, and all protocols were followed as recom-
mended by the manufacturer (Illumina, Hayward, CA, USA).
Briefly, sequencing libraries were constructed by purifying mRNA
from total RNA, which was then fragmented and converted to
double stranded cDNA using random primers. Overhangs were
converted into phosphorylated blunt ends, and adaptors were
ligated to the cDNA fragments. An agarose gel was used to remove
excess adaptors and isolate fragments roughly 300 bp long, and
PCR was used to enrich for adapter-modified fragments. Libraries
were prepared and sequenced using a barcoding scheme across
multiple sequencing pools to enable the identification of technical
artifacts. As such, each sample was sequenced to a depth of
approximately 15 million 68 base pair long paired-end reads
(Table S1).
Validation of RNA editing through Sanger sequencing
RNA and DNA was isolated from livers of two additional,
independent C57BL/6J mice. In order to account for potential
variation in protocols and reagents, one sample was prepared
using a Qiagen kit protocol, and the other using TRIzol
(Invitrogen). RNA was digested with DNase I to exclude DNA
contamination. Random primers were used for first-strand cDNA
synthesis, and Superscript III RT (Invitrogen) was used for reverse
transcription. As a control for DNA contamination, DEPC-treated
water was used in place of the reverse transcriptase enzyme. PCR
was carried out with primers specific for each RNA editing site of
interest. Primers were designed to amplify fragments of an
appropriate size for sequencing and that could be used on both
gDNA, and on potentially spliced cDNA. Amplified PCR products
were purified and subjected to Sanger sequencing using standard
methodologies. Sites were considered validated if the cDNA
sequence at the candidate editing site contained two peaks (both a
reference peak and an edited peak), while the corresponding
gDNA sequence contained a single reference peak. Sites were
considered un-validated if the cDNA and gDNA traces both
contained a single reference peak.
Validation through restriction fragment length
polymorphism (RFLP) analysis
We selected two potential editing sites for validation as their
sequences were amenable to validation with RFLP analysis.
Specifically, the editing site at chr10:57235791 in the Serinc1 gene
creates a sequence that is recognized by the restriction enzyme
BspDI, and the site at chr9:123370996 in the Lars2 gene creates an
RsaI recognition site. In both cases, site specific PCR products for
cDNA and gDNA were obtained as described above. These
products were subjected to restriction enzyme digest or a mock
control for 2 hours at 65uC for BspDI and 37uC for RsaI. To insure
enzyme integrity, two positive controls for RsaI were amplified by
PCR using specific primers and digested with or without RsaI. The
resulting fragments were visualized using standard agarose gel
electrophoresis.
Identification of RNA editing sites from RNA-seq data
Our goals for analysis were to identify high-confidence RNA
editing sites from inherently noisy high-throughput sequencing of
RNA. As such, we analyzed data to filter out poor quality
sequences and alignments, but in a manner that tolerates a large
number of mismatches in order to account for potential ‘‘clusters’’
of editing sites. First, all reads that do not meet Illumina’s chastity
filter were removed, and reads that did not contain a perfect
barcode sequence were removed, since sequencing errors early in
a read are a potential indicator of poor read quality. Second, reads
were aligned first to a custom set of all possible exon splice junction
sequences based on RefSeq annotations [25], and then to the
mouse reference genome (NCBI build 37; mm9 from http://
genome.ucsc.edu) by splitting each 68 nucleotide read into two
smaller portions which were separately aligned using the Bowtie
software [26], tolerating 2 mismatches per portion. Reads were
retained for further analysis only if all 4 segments of each paired-
end read aligned to the same location with proper orientation and
spacing.
Based on these high-quality aligned reads, we identified
potential RNA editing sites as genomic locations with mapped
reads containing at least 2 high quality mismatched bases (Phred
score .20) and where the edit ratio (percentage of mismatched or
edited reads out of all reads mapped to that location) is at least 5%.
Known SNP locations (from CDGSNPDB 1.3 Mouse [27]) were
filtered, as were locations with an editing ratio of 100% across all
samples, which are assumed to be SNPs relative to the reference
genome, or the result of other errors. In order to filter apparent
editing sites due to sequencing strand biases, we calculated a Fisher
exact test p-value for each potential editing site covered by at least
20 reads with a 262 contingency table of the number of edited
forward strand, edited reverse strand, un-edited forward strand,
and un-edited reverse strand reads from all reads aligned to the
editing site. Editing sites were deemed significantly strand biased
and filtered if their Bonferroni corrected p-value,0.05.
Evaluation of technical variability
Since we were analyzing inherently noisy data for relatively
subtle variations, we performed our sequencing using a barcoding
scheme that interleaved samples across multiple sequencing lanes
and machine runs to enable evaluation of technical variability in
sequencing. We applied ANOVA models to evaluate the
variability of gene expression levels (measured as RPKM; model
RPKM,run*tissue) and editing ratio (model: EditRatio,run*
tissue). In both cases the run effect did not significantly contribute
to variability (effect size ,0.05; Fig S7). As such, downstream
analyses pooled technical replicates together for analysis.
Distribution of editing sites and genomic background
The genomic locations of RNA editing sites were classified as
39UTR, coding, intronic, 59UTR, or intergenic based on RefSeq
gene annotations [25]. In order to determine the genomic
background, 10,000 random locations containing at least 20
mapped reads were selected and classified in the same manner. P-
values were determined by a 1000 iteration permutation test
selecting the same number of random sites and determining if their
genomic distribution is more extreme than observed. Similar
results are obtained with a coverage requirement of only 2 mapped
reads.
Enrichment of editing sites in ‘‘seeds’’ of microRNA
Editing sites were classified as within a microRNA target site if
they fall within the region complementary to the ‘‘seed’’ (2
nd to 8
th
nucleotide) of a microRNA defined by miRBase [28] and
identified by our own search through known 39UTR sequences.
Significance p-values were determined by a 1000 iteration
permutation test that randomly selects the same number of
potential sites (bases covered by at least 20 reads within a sample),
and determines how many random samples included as many or
more locations at a microRNA target site. In addition to using
sequence complementarity to define microRNA targets, we also
Canonical RNA Editing Enriched at microRNA Targets
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which produced similar results. As before, similar results are
obtained with a coverage requirement of only 2 mapped reads.
Supporting Information
Figure S1 Canonical RNA editing sites without strand
bias validated by Sanger sequencing. The gene name,
coding strand, type of edit, and genomic location are listed for
each site. The upper row of bases are oriented relative to the
gene’s strand, and the lower row of bases are oriented in the
direction of Sanger sequencing. Several sites were verified by
sequences from both directions.
(TIF)
Figure S2 Non-canonical RNA editing candidates with a
significant strand bias fail to validate through Sanger
sequencing. Results are shown as in Fig S1.
(TIF)
Figure S3 Distribution of average editing ratios for
canonical and non-canonical editing sites. A) In bone
samples, and B) in liver samples. The x-axis is sorted by editing
ratio.
(TIF)
Figure S4 Canonical sites with a strand bias, and a non-
canonical site without strand bias fail to validate. A)
Sanger sequencing of 3 canonical sites with a significant strand
bias. B) Sanger sequencing of 1 non-canonical site without a
significant strand bias.
(TIF)
Figure S5 Examples of DNA polymorphisms within the
Hjurp gene.
(TIF)
Figure S6 Motifs discovered at or near strand biased
sites. A,B) Significant motifs within 50 bp of strand biased sites
discovered with MEME [17]. C) Distribution of location of motif
in A relative to editing site. D) Motif created by aligning all strand
biased editing sites at position 51. E-H) Similar to D, but separated
by edited base.
(TIF)
Figure S7 Effect of technical sequencing variation on
gene expression and RNA editing. A) Effect sizes determined
from fitting an ANOVA model to gene expression levels
(measured as RPKMs) with respect to technical replicate (labeled
‘‘run’’) and tissue analyzed (model: RPKM,run*tissue). B) Effect
sizes based on ANOVA analysis of edit ratios similarly to A
(model: EditRatio,run*tissue). In both cases, the effect size of run
is negligible.
(TIF)
Table S1 Summary of reads and RNA editing sites identified
from each tissue.
(DOCX)
Table S2 Homologues of RNA editing sites previously validated
in human studies present in our samples.
(DOCX)
Table S3 All high confidence canonical editing sites.
(XLSX)
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